Peptides have become the beauty world's latest buzzword and one of the biggest skincare trends, with dermatologists and skincare gurus highlighting their anti-aging benefits across social media
"I don't see why one would take the path of a proper drug approval if there is now this less rigorous, alternative path to market," he said
Most big pharma companies have at least one amylin in development, the most advanced of which is Novo Nordisks CagriSema, a dual amylin/GLP-1 agonist currently under FDA review
The MHRA is asking anyone who is taking GLP-1 medicines and experiences these symptoms to seek medical advice and report it via the regulator's Yellow Card scheme
Enhancing Skin Radiance : This injectable can brighten dark spots and uneven tones, improving texture and a refreshed appearance
Swiss researchers Marcel Monnier and Guido Schoenenberger made the discovery in 1974